SFG
TEVA icon

Steward Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Steward Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$12K Buy
+1,250
New +$11.6K ﹤0.01% 338
2022
Q3 		– Sell
-1,250
Closed -$9K – 1185
2022
Q2 		$9K Hold
1,250
– – 0.01% 264
2022
Q1 		$11K Hold
1,250
– – 0.01% 204
2021
Q4 		$10K Buy
+1,250
New +$11.3K 0.01% 159

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Steward Financial Group's TEVA Position: Q3 2023 in Review

Steward Financial Group opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2023: 1,250 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #338 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in TEVA as recently as Q2 2022.

Steward Financial Group first reported a position in TEVA in Q4 2021 and has held it in 4 quarters since. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • Steward Financial Group held 1,250 shares of Teva Pharmaceuticals worth $12K as of Q3 2023.
  • Teva Pharmaceuticals was a new Steward Financial Group position in Q3 2023.
  • Teva Pharmaceuticals made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #338 holding.
  • Steward Financial Group first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.